Periprosthetic Joint Infection: Current Clinical Challenges
- PMID: 37434369
- PMCID: PMC11004930
- DOI: 10.1093/cid/ciad360
Periprosthetic Joint Infection: Current Clinical Challenges
Abstract
Over the last several decades, periprosthetic joint infection has been increasing in incidence and is occurring in more complex patients. While there have been advances in both surgical and medical treatment strategies, there remain important gaps in our understanding. Here, we share our current approaches to the diagnosis and management of periprosthetic joint infection, focusing on frequent clinical challenges and collaborative interdisciplinary care.
Keywords: antimicrobial treatment; periprosthetic joint infection; revision arthroplasty; rifampin; total joint arthroplasty.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest . S. B. N. reports honorarium from the Infectious Diseases Board Review Course (George Washington University CME) paid to author; participation on Journal of Bone and Joint Infection’s Advisory Board; a role on the education committee for the Musculoskeletal Infection Society; and stock options from Sonoran Biosciences. A. J. T. reports royalties from UpToDate and an unpaid position with the Musculoskeletal Infection Society. A. F. C. reports grants or contracts from the Clinical Process Improvement Leadership Program, Foundation for Arthroplasty Research and Education, National Institutes of Health/ National Institute of Arthritis and Musculoskeletal and Skin Diseases, Knee Society, Vela Foundation, Ruth Jackson Orthopaedic Society/Zimmer Biomet Clinical/Basic Science Research Grant, Orthopaedic Trauma Association, Agency for Healthcare Research and Quality and Patient Centered Outcomes Research Initiative Large Conference Grant Program, American Academy of Orthopaedic Surgeons (AAOS) Board of Specialty Societies Quality and Patient Safety Action Fund, and Centers for Medicare and Medicaid Services; consulting fees from Adaptive Phage Therapeutics, Avanos, Best In Class MD, Convatec, Ethicon, Gerson Lehrman Group, Guidepoint, Heraeus, IrriMax, Peptilogics, Pfizer, Stryker, and Smith and Nephew; board or committee positions with AAOS, American Joint Replacement Registry, American Association of Hip and Knee Surgeons, and the European Knee Association; stock or stock options from Hyalex, IrriMax, Osteal Therapeutics, Sonoran, IlluminOss; a grant from Ruth Jackson Orthopaedic Society/Zimmer Biomet; royalties from Stryker, SLACK Incorporated, and UpToDate; and editorial board roles for the following publications: Journal of Bone and Joint Surgery; Journal of Arthroplasty; Clinical Orthopaedics and Related Research; Journal of Bone and Joint Infection; Knee Surgery, Sports Traumatology, Arthroscopy; Journal of Orthopaedic Research; and Anthroplasty Today. The remaining author: No reported conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures




Similar articles
-
Executive Summary: Periprosthetic Joint Infection-Current Clinical Challenges.Clin Infect Dis. 2023 Oct 5;77(7):939-940. doi: 10.1093/cid/ciad457. Clin Infect Dis. 2023. PMID: 37796054 Free PMC article.
-
Periprosthetic joint infection in aseptic total hip arthroplasty revision.Int Orthop. 2020 Apr;44(4):735-741. doi: 10.1007/s00264-019-04366-2. Epub 2019 Jun 25. Int Orthop. 2020. PMID: 31240360
-
Multidrug-Resistant Organisms in the Setting of Periprosthetic Joint Infection-Diagnosis, Prevention, and Treatment.J Arthroplasty. 2018 Jan;33(1):185-194. doi: 10.1016/j.arth.2017.07.045. Epub 2017 Aug 3. J Arthroplasty. 2018. PMID: 28869114 Review.
-
Management of fungal or atypical periprosthetic joint infections.J Orthop Res. 2014 Jan;32 Suppl 1:S147-51. doi: 10.1002/jor.22559. J Orthop Res. 2014. PMID: 24464889 No abstract available.
-
New Approaches to the Diagnosis and Management of Periprosthetic Joint Infection of the Shoulder.Instr Course Lect. 2022;71:361-376. Instr Course Lect. 2022. PMID: 35254794
Cited by
-
Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review.Int Orthop. 2024 Nov;48(11):2809-2825. doi: 10.1007/s00264-024-06295-1. Epub 2024 Sep 10. Int Orthop. 2024. PMID: 39254722 Free PMC article.
-
Imaging in Periprosthetic Joint Infection Diagnosis: A Comprehensive Review.Microorganisms. 2024 Dec 24;13(1):10. doi: 10.3390/microorganisms13010010. Microorganisms. 2024. PMID: 39858778 Free PMC article. Review.
-
Outcomes after suppressive antimicrobial therapy for prosthetic joint infection: a prospective cohort study.Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0178424. doi: 10.1128/aac.01784-24. Epub 2025 Apr 22. Antimicrob Agents Chemother. 2025. PMID: 40261077 Free PMC article.
-
Changing Incidence, Aetiology and Outcomes of Prosthetic Joint Infections: A Population-Based Study in Iceland.J Clin Med. 2025 Jul 26;14(15):5289. doi: 10.3390/jcm14155289. J Clin Med. 2025. PMID: 40806913 Free PMC article.
-
Preliminary osteogenic and antibacterial investigations of wood derived antibiotic-loaded bone substitute for the treatment of infected bone defects.Front Bioeng Biotechnol. 2024 Jul 9;12:1412584. doi: 10.3389/fbioe.2024.1412584. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39055342 Free PMC article.
References
-
- Kurtz SM, Lau EC, Son M-S, Chang ET, Zimmerli W, Parvizi J. Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. J Arthroplasty 2018; 33:3238–45. - PubMed
-
- McMaster Arthroplasty Collaborative . Incidence and predictors of prosthetic joint infection following primary total knee arthroplasty: a 15-year population-based cohort study. J Arthroplasty 2022; 37:367–372.e1. - PubMed
-
- McMaster Arthroplasty Collaborative . Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a 15-year, population-based cohort study. J Bone Joint Surg Am 2020; 102:503–9. - PubMed
-
- Premkumar A, Kolin DA, Farley KX, et al. Projected economic burden of periprosthetic joint infection of the hip and knee in the United States. J Arthroplasty 2021; 36:1484–1489.e3. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical